Skip to Content

Stock photo from Pexels

Gilead Sciences stock soars after it touts Remdesivir trial results

An announcement this week by the US pharmaceutical company specializing in virus research and medicine, Gilead Sciences, caused a three percent jump in the S&P 500 index after the market closed, while the company's own shares moved up 15 percent.

Published: April 18, 2020, 6:37 am

    Read more

    The company’s drug, Remdesivir, originally developed for Ebola, produced “miraculous” results in 113 clinical Covid-19 cases in Chicago, leaving only 2 of the 113 patients dead. Remdesivir was incidentally ultimately found to be ineffective against Ebola.

    “The best news is that most of our patients have already been discharged, which is excellent. We had only two patients who died, ” said Kathleen Mullane, a University of Chicago infectious disease specialist who oversees the Remdesivir tests at the hospital.

    The announcement, published by a medical website, STAT, in the USA, immediately spread like wildfire and has caused global stock exchange rises. Most European exchanges opened more than three percent higher.

    Gilead is a giant company that is part of the S&P 500 index of the 500 largest US companies. Although it has developed cancer drugs in the past, it has specialized in viral research and antiviral drugs in recent years, targeting HIV and Ebola, among others.

    The company already has an Aids prevention tool on the market intended for people who are at “high sexual risk”, such as prostitutes and homosexuals.

    Apparently, the California biotech company is engaged in several concurrent clinical trials with Remdesivir, both in North America and Europe. Until these trials have been completed, there will be no certainty about the drug’s efficacy to fight Covid-19 though. Last month, President Donald Trump advocated Remdesivir as one of the remedies for America to curb the pandemic.

    Gilead reacted cautiously to the news from Chicago. “What we can say at this point is that we look forward to seeing the data from current studies as soon as it becomes available,” the company said in a statement.

    The Chicago trial data is for a total of 400 serious patients and will be released soon.

    The Chinese Institute of Virology in Wuhan, funded partly by the US, has already applied for a Chinese “use patent” on January 21, 2020 to use the drug in China on Covid-19 patients.

    Funding for the development of Remdesivir was advanced by the US taxpayer, to the tune of $79 million. Gilead also obtained a so-called “orphan drug” status for it on March 23 this year. This rating by the US FDA (Food and Drug Administration) is intended for drugs used by less than 200 000 Americans and ensures further financial and legal monopoly status for medical companies, along with tax exemptions and government fees.

    So not only did the US government pay for Gilead’s research, but the US taxpayer runs the risk of not receiving anything back from the company through taxes.

    Since more than 200 000 people will need treatment, the company relinquished its “orphan drug” status on March 25. However, Gilead Sciences retains patent rights to Remdesivir in more than 70 countries that will secure its profits.

    Former US Defense Secretary Donald Rumsfeld is but one of the politically connected investors in Gilead Sciences  that owns the rights to Tamiflu, the influenza remedy that was once the most-sought after drug in the world.

    Rumsfeld served as Gilead (Research)’s chairman from 1997 to 2001.

    Biospace reported earlier this week however that “about 25 percent of patients receiving [Remdesivir] have severe side effects, including multiple-organ dysfunction syndrome, septic shock, acute kidney injury and low blood pressure”.

    And even worse: “Another 23 percent demonstrated evidence of liver damage on lab tests,” Biospace reported.

    A recent global survey of over 6 000 doctors found hydroxychloroquine and azithromycin rated the “most effective” treatments for coronavirus. Both these drugs are cheap and cost around $1 for a full course, while Gilead’s Remdesivir may cost around $1 000 for a full course.

    Consider donating to support our work

    Help us to produce more articles like this. FreeWestMedia is depending on donations from our readers to keep going. With your help, we expose the mainstream fake news agenda.

    Keep ​your language polite​. Readers from many different countries visit and contribute to Free West Media and we must therefore obey the rules in​,​ for example​, ​Germany. Illegal content will be deleted.

    If you have been approved to post comments without preview from FWM, you are responsible for violation​s​ of​ any​ law. This means that FWM may be forced to cooperate with authorities in a possible crime investigation.

    If your comments are subject to preview ​by FWM, please be patient. We continually review comments but depending on the time of day it can take up to several hours before your comment is reviewed.

    We reserve the right to del​ete​ comments that are offensive, contain slander or foul language, or are irrelevant to the discussion.

    Americas

    Pennsylvania: Explosive testimonies heard on 2020 US election fraud

    GettysburgPresident Donald Trump's campaign lawyer Rudy Giuliani testified before the Pennsylvania state legislature to address the allegations of voter fraud in the 2020 election in the state on Wednesday. The Republican-held legislature heard testimonies from several election workers who had witnessed irregularities of fraud during vote counting.

    How did a bankrupt Spanish company count American votes?

    WashingtonAccording to unconfirmed reports, the server of a Spanish company, which was used for large parts of the US election count, was in Frankfurt am Main. According to the US Member of Congress Louie Gohmert, the server is said to have been confiscated after the election in a raid.

    Joe Biden stands ready to heighten global conflict

    WashingtonThe Pentagon, the State Department and an array of intelligence agencies have been sabotaging President Trump in order to wage endless wars. They are now boasting about it.

    US election glitch: Dominion voting machines and Democratic lobbyists

    WashingtonWhen Hillary Clinton brazenly declared before the 2020 US election that  "Joe Biden should not concede under any circumstances because I think this is going to drag out," she must have had insight into what the Democrats had prepared for victory.

    ‘Real competitive struggle’ – Navalny either blind or biased in assessing US elections

    Undoubtedly, the attention of the whole world is riveted on the presidential election in the USA and the disarray which has followed. This being said, the US electoral process is traditionally an issue which is not only interesting in itself but also because of estimations and reactions from some third parties.

    The legitimacy of the US electoral system has suffered a huge blow

    WashingtonThe climate around the outcome of the US presidential election continues to deteriorate. Accusations of fraud by the Trump clan continue, due to the many irregularities in voting and counting.

    Evidence mounts of a stolen US election

    WashingtonAmericans are experiencing a well designed and successful coup against American democracy and accountable government and this is not a conspiracy theory, says Paul Craig Roberts. "It is a revolution against red state America."

    Another USPS worker steps forward amid widespread reports of voter fraud

    Erie, PennsylvaniaAnother United States postal worker from Erie County, Pennsylvania, has stepped forward on Thursday with evidence of fraudulently back-dated election ballots.

    US election: Whistleblower reveals USPS mail voter fraud in Michigan

    An US Postal Service insider told Project Veritas – a conservative media organization dedicated to secretly infiltrating leftist organisations to expose their underhanded dealings – that postal clerks in Michigan were told to fraudulently hand-postmark all new ballot envelopes for November 3.

    Bookmakers and traders are betting on a Trump victory

    WashingtonBookmakers and traders are betting on a reelection victory for the incumbent president. And Democratic Party supporters in Washington are getting ready for violence.

    Go to archive